Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
The Impact of Additional Post-operative Doses of Tranexamic Acid on Pain, Mobility and Bleeding Following Total Hip and Total Knee Arthroplasty
NCT06208267Recruiting
- Sponsor
- St. Mary's Hospital Research Centre
- Start
- Aug 2025
- Primary completion
- Apr 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of tranexamic acid in Postoperative bleeding (3 arms), sponsored by St. Mary's Hospital Research Centre. Primary endpoint: Step counts at 24 and 48 hours post-operative. Started Aug 2025; status: recruiting.
02
Drugs
tranexamic acid
03
Conditions
Postoperative bleeding
Beyond the preview
Go deeper on NCT06208267.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06208267.